• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金顶侧耳(蘑菇纲)乙醇提取物可缓解饮食诱导肥胖小鼠的代谢综合征

Ethanolic Extract of the Golden Oyster Mushroom, Pleurotus citrinopileatus (Agaricomycetes), Alleviates Metabolic Syndrome in Diet-Induced Obese Mice.

作者信息

Chi Quanbo, Wang Guoyi, Sheng Yao, Xu Wentao, Shi Pengfei, Zhao Changhui, Huang Kunlun

机构信息

Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.

Department of Food and Bioengineering, Beijing Vocational College of Agriculture, Beijing, China.

出版信息

Int J Med Mushrooms. 2017;19(11):1001-1008. doi: 10.1615/IntJMedMushrooms.2017024486.

DOI:10.1615/IntJMedMushrooms.2017024486
PMID:29345562
Abstract

Pleurotus citrinopileatus is an edible medicinal mushroom rich in biomolecules and thus has a high potential for use in formulating pharmaceutical and nutraceutical products. To test its effect on body weight and glucose control, we generated diet-induced obese (DIO) C57BL/6J male mice by feeding the mice a high-fat diet (60% fat) for 8 weeks and treating them with an ethanolic P. citrinopileatus extract (PCE) at either 200 or 500 mg/kg body weight for 12 additional weeks. The results showed that PCE significantly inhibited high-fat diet-induced weight gain, fat accumulation, and glucose intolerance in the DIO mice. Moreover, the PCE had a beneficial effect on liver and kidney function. On the basis of these results, we conclude that PCE is effective in the treatment of metabolic syndrome and thus could be a good candidate for use in future pharmaceutical or nutraceutical applications.

摘要

金顶侧耳是一种富含生物分子的可食用药用蘑菇,因此在制药和营养保健品配方中具有很高的应用潜力。为了测试其对体重和血糖控制的影响,我们通过给小鼠喂食高脂肪饮食(60%脂肪)8周,然后再用体重200或500 mg/kg的金顶侧耳乙醇提取物(PCE)处理12周,构建了饮食诱导肥胖(DIO)的C57BL/6J雄性小鼠。结果表明,PCE显著抑制了DIO小鼠中由高脂肪饮食引起的体重增加、脂肪堆积和葡萄糖不耐受。此外,PCE对肝脏和肾脏功能有有益影响。基于这些结果,我们得出结论,PCE在代谢综合征的治疗中有效,因此可能是未来制药或营养保健品应用的良好候选物。

相似文献

1
Ethanolic Extract of the Golden Oyster Mushroom, Pleurotus citrinopileatus (Agaricomycetes), Alleviates Metabolic Syndrome in Diet-Induced Obese Mice.金顶侧耳(蘑菇纲)乙醇提取物可缓解饮食诱导肥胖小鼠的代谢综合征
Int J Med Mushrooms. 2017;19(11):1001-1008. doi: 10.1615/IntJMedMushrooms.2017024486.
2
Anti-obesity and hypolipidemic effect of water extract from in C57BL/6J mice.[具体物质名称]水提取物对C57BL/6J小鼠的抗肥胖和降血脂作用
Food Sci Nutr. 2019 Mar 5;7(4):1295-1301. doi: 10.1002/fsn3.962. eCollection 2019 Apr.
3
Nonvolatile Taste Components and Antioxidant Properties of Fruiting Body and Mycelium with High Ergothioneine Content from the Culinary-Medicinal Golden Oyster Mushroom Pleurotus citrinopileatus (Agaricomycetes).来自药食兼用的金顶侧耳(蘑菇目)的富含麦角硫因的子实体和菌丝体的非挥发性风味成分及抗氧化特性
Int J Med Mushrooms. 2016;18(8):689-698. doi: 10.1615/IntJMedMushrooms.v18.i8.50.
4
Evaluation of Antiarthritic Effect of Culinary-Medicinal Oyster Mushroom Pleurotus ostreatus cv. Florida (Agaricomycetes) on Complete Freund's Adjuvant Induced Arthritis in Rats.食用药用平菇佛罗里达变种(伞菌纲)对弗氏完全佐剂诱导的大鼠关节炎的抗关节炎作用评估
Int J Med Mushrooms. 2019;21(11):1123-1136. doi: 10.1615/IntJMedMushrooms.2019032636.
5
Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice.潜在益生菌动物双歧杆菌亚种乳双歧杆菌 420 可预防饮食诱导肥胖小鼠体重增加和葡萄糖不耐受。
Benef Microbes. 2014 Dec;5(4):437-45. doi: 10.3920/BM2014.0014.
6
Examining the Cultivation, Degradation Characteristics and Health Effects of the Golden Oyster Mushroom Pleurotus citrinopileatus (Agaricomycetes): A Review.金顶侧耳(伞菌纲)的栽培、降解特性及健康影响研究综述
Int J Med Mushrooms. 2023;25(4):17-26. doi: 10.1615/IntJMedMushrooms.2023047581.
7
Bioavailability and Digestibility of Nutrients from the Dried Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes): In Vivo Experiments.干制食药用菌平菇(伞菌纲)中营养成分的生物利用度和消化率:体内实验
Int J Med Mushrooms. 2016;18(8):681-688. doi: 10.1615/IntJMedMushrooms.v18.i8.40.
8
Composition of Mycelia and Basidiomata of the Culinary-Medicinal Golden Oyster Mushroom, Pleurotus citrinopileatus (Agaricomycetes) by Nuclear Magnetic Resonance Spectroscopy.利用核磁共振光谱法分析食药用真菌金顶侧耳(蘑菇目)菌丝体和子实体的组成成分
Int J Med Mushrooms. 2019;21(10):965-977. doi: 10.1615/IntJMedMushrooms.2019032676.
9
Characteristics of Exopolysaccharides from the Citrine Oyster Mushroom, Pleurotus citrinopileatus (Agaricomycetes), Depend on the Nitrogen Source in the Medium.柠檬黄平菇(侧耳属,伞菌目)胞外多糖的特性取决于培养基中的氮源。
Int J Med Mushrooms. 2018;20(7):647-655. doi: 10.1615/IntJMedMushrooms.2018026571.
10
Proximal Composition, Nutraceutical Properties, and Acute Toxicity Study of Culinary-Medicinal Oyster Mushroom Powder, Pleurotus ostreatus (Agaricomycetes).食药用平菇(糙皮侧耳,伞菌目)菌粉的近端成分、营养特性及急性毒性研究
Int J Med Mushrooms. 2018;20(12):1185-1195. doi: 10.1615/IntJMedMushrooms.v20.i12.60.

引用本文的文献

1
Pleurotus Mushrooms in Nutrition and Health: Clinical and Preclinical Insights for Nutraceutical Development.平菇在营养与健康中的作用:营养保健品开发的临床与临床前见解
Compr Rev Food Sci Food Saf. 2025 Sep;24(5):e70279. doi: 10.1111/1541-4337.70279.
2
Anti-Inflammatory Mechanisms of : Inhibition of MAPK and NF-κB Signaling Pathways, and Activation of ROS/PI3K/Nrf2/HO-1 Signaling Pathway in LPS-Stimulated RAW264.7 Cells.:在脂多糖刺激的RAW264.7细胞中,抑制MAPK和NF-κB信号通路以及激活ROS/PI3K/Nrf2/HO-1信号通路的抗炎机制
J Microbiol Biotechnol. 2025 May 15;35:e2501012. doi: 10.4014/jmb.2501.01012.
3
Nutritional Support for Liver Diseases.
肝脏病的营养支持。
Nutrients. 2023 Aug 19;15(16):3640. doi: 10.3390/nu15163640.
4
Ameliorates Obesity by Modulating the Gut Microbiota in Obese Mice Induced by High-Fat Diet.通过调节高脂肪饮食诱导肥胖小鼠的肠道微生物群来改善肥胖。
Nutrients. 2022 Apr 29;14(9):1868. doi: 10.3390/nu14091868.
5
Anti-obesity and hypolipidemic effect of water extract from in C57BL/6J mice.[具体物质名称]水提取物对C57BL/6J小鼠的抗肥胖和降血脂作用
Food Sci Nutr. 2019 Mar 5;7(4):1295-1301. doi: 10.1002/fsn3.962. eCollection 2019 Apr.